Clinical Trials Logo

Osteoarthritis, Hip clinical trials

View clinical trials related to Osteoarthritis, Hip.

Filter by:

NCT ID: NCT03558217 Completed - Hip Osteoarthritis Clinical Trials

Collared Versus Collarless Femoral Implants for Total Hip Arthroplasty

Start date: January 15, 2018
Phase: N/A
Study type: Interventional

This is a randomized control trial that will investigate whether a collared hip replacement implant provides greater stability compared to a collarless option. Stability will be measured by implant migration with radiostereometric analysis (RSA) imaging. Secondary objectives will be to compare function, quality of life and cost between the two implant types. We will also compare between two different surgical approaches, the direct anterior and direct lateral.

NCT ID: NCT03540667 Completed - Clinical trials for Osteoarthritis, Knee

Study of Hip and Knee Arthroplasty in South Africa

Start date: May 7, 2018
Phase:
Study type: Observational

This multi-site, observational, prospective study aims to investigate current practice and associated outcomes for patients scheduled for elective unilateral total hip or knee arthroplasty in South Africa.This information will provide baseline values, against which effects of implementing a multidisciplinary enhanced care protocol for arthroplasty patients will be compared (the subsequent study).

NCT ID: NCT03513276 Completed - Hip Osteoarthritis Clinical Trials

Effect of Local Infiltration Anesthesia in a Hip Arthroplasty Fast Track Program.

Start date: February 2016
Phase: Phase 4
Study type: Interventional

Fast-track programs in Orthopaedic Surgery require early motion that can only be achieved by optimal pain management protocols. Multimodal analgesia protocols including local infiltration anesthesia (LIA) have obtained excellent results in fast-track programs involving Total Knee Arthroplasty but further research and data is needed in Total Hip Arthoplasty programs.

NCT ID: NCT03491904 Completed - Clinical trials for Osteoarthritis, Knee

To Assess the Patients' Ability to Self-Administer Fasinumab

FACT DEVICE
Start date: January 23, 2019
Phase: Phase 1
Study type: Interventional

The primary objective is to demonstrate that the auto-injector(AI) is suitable to be used to administer fasinumab at home by patients or their caregivers, as measured by collecting 12 weeks of actual-use data on the technical performance of the device. The secondary objectives of the study are: - To evaluate the successful injection of fasinumab by patients or their caregivers using the AI in an unsupervised setting - To evaluate patient/caregiver satisfaction with the AI for fasinumab injection in an unsupervised setting - To evaluate exposure in serum for fasinumab administered by patients or their caregivers using an AI in an unsupervised setting, or fasinumab administered by study staff using a PFS that has been used in the phase 3 program - To characterize the safety, tolerability, and immunogenicity of fasinumab administered by patients or their caregivers using an AI in an unsupervised setting, or fasinumab administered by study staff using a PFS that has been used in the phase 3 program

NCT ID: NCT03469687 Completed - Hip Osteoarthritis Clinical Trials

Symax International Study

Start date: November 2, 2004
Phase: N/A
Study type: Interventional

The uncemented Symax hip stem is developed through optimization of the uncemented Omnifit hip stem. The Symax stem design combines an anatomical anteverted proximal geometry with a straight distal section. The proximal part is coated with a biomimetic hydroxyapatite (HA) coating for improved osseointegration to enhance load transfer and to minimize proximal bone loss. The distal part is treated with an anodization surface treatment in order to prevent distal bone apposition, which is expected to prevent distal loading and reduce proximal stress shielding. Aim of this study is to report mid-term clinical performance and evaluate whether the radiographic features are in line with the design principles of the Symax hip in an international clinical study with 5 years of follow-up.

NCT ID: NCT03467165 Completed - Osteoarthritis Clinical Trials

MRgFUS in the Treatment of Hand and Hip Osteoarthritic Pain

Start date: April 27, 2019
Phase: N/A
Study type: Interventional

This project aims at performing a pilot study to provide data on safety and potential efficacy of Magnetic Resonance guided Focused Ultrasound Surgery (MRgFUS) in the treatment of pain caused by trapeziometacarpal osteoarthritis (OA) and/or scaphotrapezial OA, and by hip OA, while exploring the potential application of MRgFUS to two different and central joints burdened by OA.

NCT ID: NCT03450733 Completed - Osteoarthritis, Hip Clinical Trials

Wright Medical Technology Metal-on-Metal 522 Post-Market Surveillance Study

Start date: April 11, 2018
Phase:
Study type: Observational

This study is in response to the Food and Drug Administration (FDA) call to all manufacturers with 510(k) clearance for metal-on-metal (MoM) total hip arthroplasty (THA) devices to conduct postmarket surveillance studies. MicroPort has various acetabular shells, acetabular liners, fixation screws, femoral heads, femoral stems, modular necks, and proximal bodies currently cleared for MoM indications. Together these components comprise the Wright Medical Technology (WMT) MoM THA System. The primary objective of the study is to determine the incidence of adverse local tissue reactions (ALTR) in each THA implanted with the WMT MoM THA System overall and to create cross-sectional epochs of ≤ 8 years and > 8 years, since implantation.

NCT ID: NCT03428893 Completed - Clinical trials for Osteoarthritis of Knee

Mobile Technology to Support Physical Therapy Exercise

MyTherEx
Start date: January 8, 2018
Phase: N/A
Study type: Interventional

Osteoarthritis is the leading cause of disability in the U.S, particularly in older adults. Exercise is an evidence-based treatment option that improves pain and disability outcomes in adults with osteoarthritis, but adherence to prescribed exercise is generally low. Technology such as mobile applications (apps) for smartphones and tablets offers the potential to support exercise adherence through evidence-based components and enhanced communication between physical therapists and patients. The investigators aim to test mobile app-supported physical therapy exercise prescription compared to standard care. The investigators propose to use a two-arm randomized control trial with subjects in the intervention receiving mobile app-supported physical therapy exercise prescription and the control group receiving usual care physical therapy exercise prescription (paper handouts and verbal instruction). No known studies have assessed the impact of technological integration on adherence with PT exercises for OA. Current approaches such as therapist drawn pictures, hand-written or print-ready instructions do not account for patient communication preferences or ability to translate drawings into physical action. Mobile technology offers a potential solution to patient-centered care but has not been evaluated. This study will provide valuable information on effectiveness and user perspectives to key stakeholders such as patients, health care administrators, physical therapists and app designers.

NCT ID: NCT03409666 Completed - Clinical trials for Rheumatoid Arthritis

Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.

Start date: May 12, 2017
Phase: N/A
Study type: Interventional

This is a single center, prospective, randomized controlled study. The primary objective of this study is to measure migration over two years with RSA. Patients will be randomized in two arms, receiving a Taperloc Complete Reduced Distal or a Taperloc Complete Microplasty hip stem.

NCT ID: NCT03393923 Completed - Gait, Frontal Clinical Trials

Anterior Wedge in Patients With Osteoarthritis Hip

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

Ostearthritis is a great source of pain. In symptomatic hip the pain can lead the major disability and poor quality of life. Understand the musculoskeletal factores can lead to a better clinical management. The muscle strenghening of posterolateral complexo of hip is a important consideration. General Objective: Perform a Kinetic analysis 2D using na anterior wedge. Specific objective: Analyze the influence of posterolateral hip complex. Controlled clinical trial, composed by 30 individuals with and without osteoarthritis of hip e will be used a tools; Analogic Visual Scale, manual dynamometry to analyze force and kinetic analyze of gait through of Myovídeo analysis software.